Atlas Trials

Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Clinical trial NCT04250207 · COMPLETED

Trial details

NCT number
NCT04250207
Sponsor
Kowa Research Institute, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fuchs' Endothelial Corneal Dystrophy
Start date
2020-06-23
Primary completion
2021-09-22
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.